Exeon Analytics to sell cyberattack solution licenses
Zurich – Exeon Analytics has developed a solution based on machine learning to protect companies from cyberattacks. The spinoff from the Swiss Federal Institute of Technology in Zurich plans to start selling the first licenses in the coming weeks.
Researchers develop vaccine for allergic diseases in animals
Zurich – Scientists at the universities of Zurich and Bern have developed a new vaccine that can help treat allergic diseases in dogs and horses. The findings could lead to similar therapeutic vaccines for humans.
New antibodies to combat the flu
Zurich – Together with scientists from the USA, researchers from the University of Zurich have discovered a new way in which certain antibodies interact with the flu virus. These findings could help in developing more efficient medication and vaccines.
Swisscom Blockchain joins forces with Digipharm
Zug – Swisscom Blockchain and Digipharm are working together to develop blockchain-based platforms for healthcare. Their shared aim is to bring about fair pricing and personalised therapy.
Hong Kong bitcoin exchange plans move to Switzerland
Zurich – One of the largest cryptocurrency exchanges in the world wants to relocate its headquarters to Switzerland, a move that will make Bitfinex the most transparent stock exchange of them all. Switzerland hopes for a knock-off effect for the crypto-scene.
Kickstart Accelerator opens third edition
Zurich – Kickstart Accelerator has launched the third edition of its programme in Zurich. Switzerland’s largest innovation acceleration programme, it initiates successful partnerships between startups, established companies and institutions.
Physicists build a more affordable brain scanner
Zurich – Two scientists at the Federal Institute of Technology in Zurich are building a brain scanner that is considerably less expensive and smaller than current models. The two have now earned a place in the “30 Under 30” list published by the U.S. business magazine Forbes.
Researchers speed up search for drugs
Zurich – Researchers at the Swiss Federal Institute of Technology in Zurich have developed a method for examining drug candidates. This makes the search for drugs cheaper and more efficient.
Students develop therapy device for skin disease
Zurich – Students from the Greater Zurich Area have developed a therapy device for the treatment of the skin infection leishmaniasis. It can be manufactured cheaply and could be used in developing countries, in particular.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space